中枢神经系统结节病脑脊液细胞因子与趋化因子谱:诊断与免疫病理学见解
这项病例对照研究在中枢神经系统结节病(NS)患者脑脊液中验证了17种细胞因子/趋化因子,发现12种水平显著高于非炎症对照组,且脑脊液升高较血清更常见;多种因子联合升高仅见于NS患者,部分因子与疾病活动度相关。
要点
- NS患者脑脊液IL-2、IL-6、IL-10、IL-13、BAFF、IL-8/CXCL8、CXCL9、CXCL10、CXCL13、GM-CSF、干扰素-γ和TNF-α水平显著高于非炎症对照组。
- IL-6、CXCL9、CXCL10、GM-CSF、干扰素-γ和TNF-α联合升高见于18/32例NS患者,对照组仅1例。
- IL-6、IL-10、IL-13、CXCL9、CXCL10、GM-CSF和TNF-α升高与疾病活动度指标相关。
核心结论
- NS脑脊液细胞因子/趋化因子谱提示T细胞(主要为1型辅助性T细胞)、巨噬细胞和B细胞参与。
- 这些特征有助于NS诊断、提示疾病活动度并提示治疗方向。
研究设计与样本
- 病例对照研究,纳入2011年1月至2023年2月期间具有钆增强和/或脑脊液细胞增多的 probable 或 definite 中枢神经系统NS症状患者。
- 采用多重自动化免疫分析系统(ELLA;Bio-Techne,明尼阿波利斯,明尼苏达州,美国)验证17种细胞因子/趋化因子,并在脑脊液和血清中评估。
- 纳入32例NS患者(59%女性;中位年龄59岁[19-81]),其中12例有同期血清。
- 对照包括26例多发性硬化、8例原发性中枢神经系统淋巴瘤、84例水通道蛋白-4免疫球蛋白G阳性患者和34例非炎症性疾病患者,另以健康个体为对照。
主要发现
- 32例NS患者中31例存在钆增强,27例(84%)存在脑脊液细胞增多。
- NS患者脑脊液IL-2、IL-6、IL-10、IL-13、BAFF、IL-8/CXCL8、CXCL9、CXCL10、CXCL13、GM-CSF、干扰素-γ和TNF-α水平显著高于非炎症对照组(p ≤ 0.02)。
- 上述因子在脑脊液中的升高较血清更常见。
- IL-6、CXCL9、CXCL10、GM-CSF、干扰素-γ和TNF-α联合升高见于18/32例NS患者,对照组仅1例。
- IL-6、IL-10、IL-13、CXCL9、CXCL10、GM-CSF和TNF-α升高与疾病活动度指标相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the cerebrospinal fluid (CSF) cytokine/chemokine profile of central nervous system (CNS) neurosarcoidosis (NS), and its utility in differential diagnosis, treatment, and prognostication. METHODS: In this case-control study, we validated 17 cytokines/chemokines (interleukin [IL]-1-beta, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12p70, IL-13, IL-17A, BAFF, IL-8/CXCL8, CXCL9, CXCL10, CXCL13, GM-CSF, interferon-gamma, and tumor necrosis factor [TNF]-alpha) in a multiplexed automated immunoassay system (ELLA; Bio-Techne, Minneapolis, MN, USA), and assessed them in CSF and serum of symptomatic patients with probable or definite CNS NS (01/2011-02/2023) with gadolinium enhancement and/or CSF pleocytosis. Patients with multiple sclerosis, primary CNS lymphoma, aquaporin-4 immunoglobulin G positivity, non-inflammatory disorders, and healthy individuals were used as controls. RESULTS: A total of 32 NS patients (59% women; median age, 59 years [19-81]) were included; concurrent sera were available in 12. CSF controls consisted of 26 multiple sclerosis, 8 primary CNS lymphoma, 84 aquaporin-4 immunoglobulin G positive, and 34 patients with non-inflammatory disorders. Gadolinium enhancement was present in 31 of 32 NS patients, and CSF pleocytosis in 27 of 32 (84%). CSF IL-2, IL-6, IL-10, IL-13, BAFF, IL-8/CXCL8, CXCL9, CXCL10, CXCL13, GM-CSF, interferon-gamma, and TNF-alpha levels were significantly higher in NS patients compared with non-inflammatory controls (p ≤ 0.02); elevations were more common in CSF than serum. Concurrent elevation of IL-6, CXCL9, CXCL10, GM-CSF, interferon-gamma, and TNF-alpha was present in 18 of 32 NS patients, but only in 1 control. Elevated IL-6, IL-10, IL-13, CXCL9, CXL10, GM-CSF, and TNF-alpha associated with measures of disease activity. INTERPRETATION: NS CSF cytokine/chemokine profiles suggest T cell (mainly T helper cell type 1), macrophage, and B-cell involvement. These signatures aid in NS diagnosis, indicate disease activity, and suggest therapeutic avenues. ANN NEUROL 2024;96:704-714.
引用
- Mangioris G, Pittock SJ, Yang B, et al. Cerebrospinal Fluid Cytokine and Chemokine Profiles in Central Nervous System Sarcoidosis: Diagnostic and Immunopathologic Insights. Ann Neurol. 2024. PMID: 39031103. doi:10.1002/ana.27024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。